These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 34918882
21. Vascular endothelial growth factor and carotid intima-media thickness in patients with Behçet's disease. Oztürk MA, Unverdi S, Oktar SO, Bukan N, Gülbahar O, Ureten K, Göker B, Haznedaroglu S, Sungur G, Ciftçi TU, Onat AM. Clin Rheumatol; 2008 Aug; 27(8):961-6. PubMed ID: 18204875 [Abstract] [Full Text] [Related]
22. Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer. Chang YT, Chang MC, Wei SC, Tien YW, Hsu C, Liang PC, Tsao PN, Jan IS, Wong JM. Pancreas; 2008 Aug; 37(2):145-50. PubMed ID: 18665074 [Abstract] [Full Text] [Related]
23. Association between baseline VEGF/sVEGFR-2 and VEGF/TSP-1 ratios and response to metronomic chemotherapy using cyclophosphamide and celecoxib in patients with advanced breast cancer. Perroud HA, Rico MJ, Alasino CM, Pezzotto SM, Rozados VR, Scharovsky OG. Indian J Cancer; 2013 Aug; 50(2):115-21. PubMed ID: 23979202 [Abstract] [Full Text] [Related]
24. Reduced serum vascular endothelial growth factor receptor-2 (sVEGFR-2) and sVEGFR-1 levels in gastric cancer patients. Kikuchi S, Obata Y, Yagyu K, Lin Y, Nakajima T, Kobayashi O, Kikuichi M, Ushijima R, Kurosawa M, Ueda J. Cancer Sci; 2011 Apr; 102(4):866-9. PubMed ID: 21219538 [Abstract] [Full Text] [Related]
26. The relationship between the VEGF/sVEGFR-1 ratio and threatened abortion. Keskin U, Ulubay M, Dede M, Ozgurtas T, Koçyiğit YK, Aydin FN, Ergün A. Arch Gynecol Obstet; 2015 Mar; 291(3):557-61. PubMed ID: 25200689 [Abstract] [Full Text] [Related]
27. Could be serum uric acid a risk factor for thrombosis and/or uveitis in Behcet's disease? Atıl A, Deniz A. Vascular; 2018 Aug; 26(4):378-386. PubMed ID: 29360007 [Abstract] [Full Text] [Related]
28. Circulating vascular endothelial growth factor (VEGF) and its soluble receptor 1 (sVEGFR-1) are associated with inflammation and mortality in incident dialysis patients. Yuan J, Guo Q, Qureshi AR, Anderstam B, Eriksson M, Heimbürger O, Bárány P, Stenvinkel P, Lindholm B. Nephrol Dial Transplant; 2013 Sep; 28(9):2356-63. PubMed ID: 23828162 [Abstract] [Full Text] [Related]
29. Overweight and obesity versus concentrations of VEGF-A, sVEGFR-1, and sVEGFR-2 in plasma of patients with lower limb chronic ischemia. Wieczór R, Wieczór AM, Gadomska G, Stankowska K, Fabisiak J, Suppan K, Pulkowski G, Budzyński J, Rość D. J Zhejiang Univ Sci B; 2013 Sep; 17(11):842-849. PubMed ID: 27819131 [Abstract] [Full Text] [Related]
30. [Assessment of pro- and antiangiogenic factors blood serum concentrations in patients with hormonal inactive adrenal tumors]. Korzeniewska M, Kołomecki K, Stepień H, Naze M, Stepień T, Kuzdak K. Endokrynol Pol; 2005 Sep; 56(1):39-44. PubMed ID: 16335673 [Abstract] [Full Text] [Related]
31. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model. Maehana S, Nakamura M, Ogawa F, Imai R, Murakami R, Kojima F, Majima M, Kitasato H. Biomed Pharmacother; 2016 Dec; 84():660-665. PubMed ID: 27697638 [Abstract] [Full Text] [Related]
32. The role of vitamin D receptor gene polymorphisms in the pathogenesis of Behçet's disease: A case-control study in Turkish population. Dal NE, Cerci P, Olmez U, Keskin G. Ann Hum Genet; 2019 May; 83(3):177-186. PubMed ID: 30730049 [Abstract] [Full Text] [Related]
33. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy. Matsunaga N, Chikaraishi Y, Izuta H, Ogata N, Shimazawa M, Matsumura M, Hara H. Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666 [Abstract] [Full Text] [Related]
34. Soluble endothelial protein C receptor levels in Behçet patients with and without ocular involvement. Yalçindağ FN, Batioğlu F, Ozdemir O, Cansizoğlu E, Eğin Y, Akar N. Graefes Arch Clin Exp Ophthalmol; 2008 Nov; 246(11):1603-8. PubMed ID: 18604550 [Abstract] [Full Text] [Related]
35. Tumor necrosis factor gene polymorphisms in Tunisian patients with Behcet's disease. Kamoun M, Chelbi H, Houman MH, Lacheb J, Hamzaoui K. Hum Immunol; 2007 Mar; 68(3):201-5. PubMed ID: 17349875 [Abstract] [Full Text] [Related]
36. TNF and TNF receptor polymorphisms in Korean Behcet's disease patients. Lee EB, Kim JY, Lee YJ, Park MH, Song YW. Hum Immunol; 2003 Jun; 64(6):614-20. PubMed ID: 12770792 [Abstract] [Full Text] [Related]
37. Endothelial nitric oxide synthase gene polymorphisms in Behçet's disease and rheumatic diseases with vasculitis. Kim JU, Chang HK, Lee SS, Kim JW, Kim KT, Lee SW, Chung WT. Ann Rheum Dis; 2003 Nov; 62(11):1083-7. PubMed ID: 14583572 [Abstract] [Full Text] [Related]
38. TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behçet's disease. Akman A, Sallakci N, Coskun M, Bacanli A, Yavuzer U, Alpsoy E, Yegin O. Br J Dermatol; 2006 Aug; 155(2):350-6. PubMed ID: 16882174 [Abstract] [Full Text] [Related]
39. The effects of neoadjuvant anastrozole and tamoxifen on circulating vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in breast cancer. Banerjee S, Pancholi S, A'hern R, Ghazoui Z, Smith IE, Dowsett M, Martin LA. Clin Cancer Res; 2008 May 01; 14(9):2656-63. PubMed ID: 18451229 [Abstract] [Full Text] [Related]
40. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation? Pay S, Abbasov T, Erdem H, Musabak U, Simsek I, Pekel A, Akdogan A, Sengul A, Dinc A. Clin Exp Rheumatol; 2007 May 01; 25(4 Suppl 45):S70-5. PubMed ID: 17949555 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]